Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 15

Trial Status

Completed3
Terminated1
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT02186509Phase 1Completed
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+11 more
PrincipalinvestigatorStart date: 2015-01-30
NCT01703507Phase 1Completed
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma
Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
PrincipalinvestigatorStart date: 2012-11-09
NCT00328575Phase 1Completed
Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases
Neoplasm Metastasis
Principalinvestigator
NCT01324635Phase 1Terminated
Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors
Brain MetastasisHigh-grade MeningiomaRecurrent Glioma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Glenn Lesser

Wake Forest University Health Sciences

Related
7 trials

Shared therapeutic areas:

Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
Similarity Score13%

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Anaplastic Astrocytoma+4 more

Worked with same sponsors:

Millennium Pharmaceuticals, Inc.
Similarity Score10%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Oligodendroglioma, AdultStage IV Melanoma
Similarity Score3%

Jonathan McConathy, MD, PhD

University of Alabama at Birmingham

Related
6 trials

Shared therapeutic areas:

Recurrent Glioma
Similarity Score1%

Jiayi Huang, M.D.

Washington University School of Medicine

Related
7 trials

Shared therapeutic areas:

Oligodendroglioma, Adult
Similarity Score1%

Shimon Slavin, MD

Hadassah Medical Organization

Related
10 trials

Shared therapeutic areas:

Neoplasm Metastasis

Worked with same sponsors:

Novartis
Similarity Score1%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Neoplasm Metastasis
Similarity Score1%

Arkadiusz Dudek, MD

Masonic Cancer Center, University of Minnesota

Related
9 trials

Shared therapeutic areas:

Stage IV Melanoma

Worked with same sponsors:

Millennium Pharmaceuticals, Inc.
Similarity Score1%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Neoplasm Metastasis
Similarity Score1%

won ki kang, MD

Samsung Medical Center

Related
9 trials

Shared therapeutic areas:

Neoplasm Metastasis
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT02186509Phase 1PrincipalInvestigator

Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas

Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+11 more
Completed
NCT01703507Phase 1PrincipalInvestigator

Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma

Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
Completed
NCT00328575Phase 1PrincipalInvestigator

Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases

Neoplasm Metastasis
Completed
NCT01324635Phase 1PrincipalInvestigator

Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors

Brain MetastasisHigh-grade MeningiomaRecurrent Glioma
Terminated
NCT02145910Phase 1PrincipalInvestigator

Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases

Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
Withdrawn

All 5 trials loaded